Saccharomyces boulardii combined with triple therapy alter the microbiota in the eradication of Helicobacter pylori infection

Abstract excerpt

To assess the effectiveness and safety of combining Saccharomyces boulardii powder with triple therapy as a primary approach for eradicating H. pylori infection, a total of 144 patients who tested positive for H. pylori and diagnosed with non-ulcer dyspepsia underwent endoscopy at two national centers between June 2017 and March 2019 were included. The patients were categorized into three groups using a...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gastric Cancer Management and Outcomes
• Share to Helicobacter pylori-related gastroenterology studies
• Share to Microbial Metabolites in Food Biotechnology